Press Releases

• Amarin: Applauds Breakthroughs In Therapies for Patients With Elevated Triglycerides; Company’s VASCEPA/VAZKEPA (Icosapent Ethyl) Franchise Well Positioned to Benefit Globally From Broadened Category Commercialization More
• Anavex Life Sciences: Appoints Senior Vice President Global Head of Neurology More
• CorMedix Therapeutics: Leadership and Board Updates More
• Force Therapeutics: Celebrates 2025 Research Impact More
• Johnson & Johnson: Celebrates Innovation in Cancer Research With 2025 Dr. Paul Janssen Award More
• MiNK Therapeutics and University of Wisconsin–Madison: Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease More
• Schrödinger: Partners With Lilly to Make TuneLab Platform Available in LiveDesign More
• Tris Pharma: Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain More
• Visby: Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs More More*
• Whitehawk Therapeutics: Advances to Clinical Stage With IND Clearance for HWK-007 and IND Submission for HWK-016 More

Financial News

• Aquestive Therapeutics: Regulatory Development for Anaphylm (dibutepinephrine) Sublingual Film and Business Update More
• AtaiBeckley: Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference More
• Cellectis: 2026 Strategy and Catalysts More
  
• CSIT Awards Nearly $1.3M to 17 NJ Startups More
  
• Get Full Access to BYTE51 Life Sciences Intelligence for 50% Off More
• Johnson & Johnson: Reaches Agreement With U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments More More*
  
• JPM Week Conference Readiness Packages (Big4Bio Subscriber Discount) More
• Mesoblast: Ryoncil Sales Increase 60% in December Quarter to US$35.1M More
• PTC Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• Revolution Medicines Takeout Speculation Spotlight Shines on Merck & Co. More* More*

Media/Misc Coverage

• BioPharmGuy News: Website Archaeology, Magic Pills, Sickness is Health, Reverse Food Funnel More
• 5 Notable Northwell Health Advances of 2025 More
• More on Lexeo Therapeutics, J&J Teaming Up to Test Heart Pump Technology for Cardiac Gene Therapy Delivery More
  
• More on Octapharma Receiving FDA Approval for New Fibryga Formulation in AFD More
  
• Subscribe to LifeSci Startup for Updates on US Startups More
• The Big4Bio Podcast: Biotech Showcase Readies as Biotech Stocks and Deals Pick Up Podcast
• The Big4Bio Podcast: Every Moment Matters: DMPK’s Role in Making Better Drugs and Better Decisions Podcast
• The Rockefeller University: How the Brain Creates Facial Expressions More
• The Rockefeller University: Scientists Have Gotten Good at Blocking Enzymes to Treat Disease. Here’s What They Need to Learn Next. More

Companies

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
• Biopharmas Axed 47% More Employees Year Over Year More
• How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences More
• ICYMI: CEO's Perspective: Big Moves Come with Big Responsibilities More
  
• ICYMI: CEO's Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• ICYMI: The Power of Peer Learning: Why Even Top Biotech Leaders Need Mentorship More
• ICYMI: What’s Next in Precision Medicine: Leadership Challenges and Opportunities More

• BLPN Investor Summit Jan 8-10
• J.P. Morgan Healthcare Conference Jan 12-15
• ABD Capital Connect @ JPM Week 2026 Jan 12-13
  
• Biotech Showcase Jan 12-14
• Fierce JPM Week Jan 13-14
• PepTalk 2026 Jan 19-27
• SLAS2026 International Conference & Exhibition Feb 7-12
• IO360° Summit Feb 10-12
  

NYC Sponsors